dpp 4 inhibitors vs glp 1 agonist DPP-4 and GLP-1RAs: cardiovascular safety and benefits | Military Medical Research GLP-1 analogues and DPP-4 inhibitors

Experimental design and treatment CB6F1 mice were assigned to receive either weekly i.p

doi: 10.3390/jcm11154611 7

Weekly cycling: 5 on, 2 off The most common approach for GH secretagogues

To view or add a comment, sign in More Relevant Posts STRUCTUREACTIVITY RELATIONSHIPS (SAR) Where chemistry defines clinical effect Small structural changes major pharmacologic outcomes Functional groups Hydrogen bonding & ionic interactions or potency Stereochemistry Enantiomers differ in efficacy, safety, and metabolism Lipophilicity (logP) Controls membrane penetration, tissue distribution, CNS access pKa & ionization Determines absorption, bioavailability, and receptor binding Ring systems & rigidity Influence receptor selectivity and intrinsic activity Metabolic hotspots Steric shielding reduces CYP metabolism half-life Key insight: Clinical response begins at the molecular level dose optimization starts with structure optimization

GHK-Cu 50mg GHK-Cu (Copper Peptide), a naturally occurring peptide composed of three amino acids (glycyl-L-histidyl-L-lysine), has been extensively studied for its potential in wound healing, tissue regeneration, and skin rejuvenation